ESMO Preceptorship on Colorectal Cancer Prague 2016

Oncology Meeting Resources

06 Jul - 07 Jul, Prague, Czech Republic

ESMO Preceptorship on Colorectal Cancer square

The ESMO Preceptorship on Colorectal Cancer Prague 2016 was designed for learning about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings; understanding the importance of pathology and histoprognostic factors; learning about the management of patients after progression, side-effects of treatments and in special situations  

Presentations of the ESMO Preceptorship on Colorectal Cancer Prague 2016 are available to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful links

Presenter Presentation title Session title
A. Cervantes, ES ESMO Preceptorship on Colorectal Cancer Welcome and Introduction
D. Aust, DE The Point of View of the Pathologist Session 1 Early colorectal cancer
R. Glynne-Jones, UK State_of_the_art: Standard(s) of Radio/Chemotherapy for Rectal Cancer Session 1 Early colorectal cancer
A. Cervantes, ES Adjuvant Chemotherapy of Rectal Cancer Session 1 Early colorectal cancer
D. Aust, DE Microsatellite Instability and Other Molecular Markers - How Useful Are They? Session 2 Adjuvant settings of colorectal cancer
C. H. Köhne, DE Adjuvant Treatment for Colon Cancer III Session 2 Adjuvant settings of colorectal cancer
J. Y. Douillard, FR Adjuvant Treatment of Stage II: Which Patients to Treat? Session 2 Adjuvant settings of colorectal cancer
M. Traila, RO Metastatic Colon Cancer Participants clinical case discussion
D. Paez, ES Rapidly Progressive Colon Cancer: a Case Report Participants clinical case discussion
A. Madi, UK A Case of Metastatic Colorectal Cancer with Poor Response to Standard Therapies Participants clinical case discussion
R. Glynne-Jones, UK Standard of Care for Anal Canal Squamous Carcinomas Session 3 - Anal canal tumours
P. Piso, DE Salvage Surgery of Anal Canal Squamous Carcinomas Session 3 - Anal canal tumours
A. Cervantes, ES Review of the ESMO Consensus Conference on Metastatic Colorectal Cancer Session 4 - Metastatic colorectal cancer, liver limited metastases
C. H. Köhne, DE Development of Conventional Chemotherapy in mCRC, BSC vs, Chemo, Biochemical Modulation, Oral Fluoropyrimidines, Development of Combination Chemotherapy Session 4 - Metastatic colorectal cancer, liver limited metastases
C. H. Köhne, DE Unresectable or Borderline Resectable (Group 1) Chemotherapy +/- Targeted Agents Session 4 - Metastatic colorectal cancer, liver limited metastases